Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Ramirez Julio A. Ramirez, 1*Frederick J. Angulo, 2Ruth L. Carric October 23, 2022 IDWEEK 2022 Clostridium Difficile

Impact of misdiagnosis of Clostridioides difficile infection (CDI) by standard-of-care specimen collection and testing on estimates of hospitalized CDI incidence among adults in Louisville, Kentucky, 2019-2020

View Presentation
Oral Presentation
Donskey C, Liles E, Szymokowiak K, Lawrence J, Bouguermouh S, Zhang H, Koury K, Kitchin N, Bailey R, Smith H, Kalina W, Klein N, Dubberke E, Wilcox M, Martin E, Pride M, Anderson A, Gruber W, Jansen K, Lockhart S, Webber C April 18, 2023 ECCMID 2023 Clostridium Difficile

Efficacy and safety of Clostridioides difficile vaccine in adults ≥ 50 years old: Results from the CLOVER trial

View Presentation